Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Hyaluronic Acid in Hemophilic Arthropathy
NCT02601170Completed
- Sponsor
- Tri-Service General Hospital
- Start
- Jun 2014
- Primary completion
- May 2016
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
01
Overview
Randomised, open-label trial of platelet-rich plasma in hemophilic arthropathy (HA), sponsored by Tri-Service General Hospital. Primary endpoint: Visual Analogue Scale at 6 months. Started Jun 2014; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
hemophilic arthropathy (HA)
Beyond the preview
Go deeper on NCT02601170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02601170.